Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. - Wikidata - awgldk - TriplyDB

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

http://www.wikidata.org/entity/Q36439933

about

Cytokines as Mediators of Pain-Related Process in Breast Cancer Treatment of Cancer Pain by Targeting Cytokines Neuropathic cancer pain: What we are dealing with? How to manage it?Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets.CXCR1/2 pathways in paclitaxel-induced neuropathic pain Pain in cancer survivors The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity.Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients.[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery Forced exercise attenuates neuropathic pain in chronic constriction injury of male rat: an investigation of oxidative stress and inflammation The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma.Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.Glutathione alleviated peripheral neuropathy in oxaliplatin-treated mice by removing aluminum from dorsal root ganglia.Mechanisms of distal axonal degeneration in peripheral neuropathies.Primary culture of trigeminal satellite glial cells: a cell-based platform to study morphology and function of peripheral glia Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma.Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.Effect of ethyl pyruvate on Paclitaxel-induced neuropathic pain in rats.Preventive Effects of Bee Venom Derived Phospholipase A₂ on Oxaliplatin-Induced Neuropathic Pain in Mice.Taxane-Induced Peripheral Neurotoxicity.Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.Chemotherapy-Induced Neurotoxicity: Evidence of a Protective Role of CC Homozygosis in the Interleukin-1β Gene-511 C>T Polymorphism.Blocking of cytokines signalling attenuates evoked and spontaneous neuropathic pain behaviours in the paclitaxel rat model of chemotherapy-induced neuropathy.HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy.Role of Complement in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy.Pain in cancer survivors.From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation.Probiotic DSF counteracts chemotherapy induced neuropathic pain.

P2860

Q26774863-CB276FC0-C822-44CC-ABDA-F8241B07772B Q26779917-9B4E5428-3C92-4722-BA00-E905FEE609F2 Q26998945-92E48BCF-522D-4A62-ADD9-F89C6A7F3718 Q27011451-5CD9F504-4C35-4EB5-8A3D-C177FAEB17A7 Q28075341-66A64466-3EC0-4609-B250-F682C1149BD8 Q33614346-456A50D5-5D16-4543-AFA0-9142AC7746C5 Q33618624-279A11A1-78A2-420F-9F8E-9D9494A205C8 Q33650576-961647C5-AEDC-4F33-BA10-95FBFCF169C1 Q33672384-9138EBC1-504F-4CDE-92CA-5C25DA1DF973 Q33744706-9D360406-AD20-4044-9EE0-D135A96FE0F6 Q33770708-5A1EE663-2AC8-45E8-803E-E8A747093C32 Q33824948-ADAB35E6-8DE1-4F0F-A9C7-782D4E82BA7B Q33839314-F3A763C7-168C-4FC1-8D4C-28439D584D4F Q33879278-D9EEE8C3-5CF5-4FDB-BFA7-0B035EF42E98 Q33947251-77244BD5-2FCA-44F4-885F-F84011901A9A Q34765028-5A8B32B2-6DCD-425B-B5A0-EB7D86389713 Q36037229-6E8D4E56-70F1-4E21-85CB-851DEC1B2E02 Q36261283-D37488C3-C4B3-4FE0-90BB-F278F1D3865E Q37216797-07972FF4-0455-440B-BCA3-DE33E4D99230 Q37399781-3DFC536E-6545-451D-BA71-C399DA74339E Q37541146-B9C4D002-D6C2-4508-99F3-F9CE6DA14F0E Q37695948-5A52B7A7-4097-48CE-9E57-AACC6BCEDF1A Q37732947-1086579E-9526-4F34-9B90-BE3DCD0DFB6D Q38330759-A3E6791E-43E5-440C-AE14-E5954EEF0107 Q38372082-5BE3DB21-99BA-4613-A870-261DF49887AE Q38522262-EE395801-A3EB-42E2-B406-CFF99848353B Q38738098-22258E7E-03AE-49BF-8F7D-0A332611A4A6 Q39668102-5DCC1D4B-FB23-4FA0-B9F1-F1B99D9D99C7 Q39919930-E08C3EAB-A072-4011-BF0D-19B97CCB06C8 Q43066432-C548A6B7-17FA-42C9-A901-C2C77293E339 Q45759415-366F5FD1-CDA3-48CB-BFDE-4662CA6C1A35 Q47564629-0E515146-71C2-4BB5-9F2E-878A7673EDAD Q48006919-FF759B87-225D-45EC-B957-50CFEA3CE930 Q49543595-DD25D75B-51E5-41A6-A9D3-ACA858CCF886 Q50858728-E5940BBC-5889-41DB-AADE-538F96107423 Q52563027-91966101-3C59-4BED-8E89-3FB218C03051 Q54960570-645761EC-4544-46BB-912A-A350C047FDFF Q55001002-24CC8581-513F-4B53-B1F0-3F9C80648B01 Q55370630-BE8CED5B-0ED3-40B2-9550-D6E3C9BE5CC0

P2860

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

http://www.wikidata.org/entity/Q36439933

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

@ast

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

@en

type

label

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

@ast

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

@en

prefLabel

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

@ast

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

@en

P1433

Q36439933-BCA79E61-6842-48CC-AE7A-1C6488CCD0A3

P1476

Q36439933-AA232F33-B43C-4BF4-BC89-A4043CAE08B6

P2093

Q36439933-A14867F8-44BB-4E95-A838-8BADD0A21188

Q36439933-A28936F3-03ED-4F50-96EC-1158BE2B9C3F

Q36439933-AABF2835-53A8-4EA7-A4AF-E6B9E990341B

Q36439933-EE454ED4-458E-40A4-BA2F-664970F217AE

P2860

Q36439933-02FEE9A0-F3C6-4FDD-9B8A-BFA6B8D7A7A6

Q36439933-036D35BF-3A0E-4863-94A2-73BE4AB0E5A4

Q36439933-037791E2-3B1F-4942-89CA-F21CB126385C

Q36439933-0AADDF90-4A01-4892-8FA6-7E0F89B3009E

Q36439933-0B148F4F-313B-4104-A739-EE34057E7876

Q36439933-0BFCE5F5-AFF7-4E5C-8431-08B3C108A8DD

Q36439933-1AD5988E-ECD4-4C82-AFED-21073DD497A6

Q36439933-21F79AA6-DEE7-48E2-AD08-B45C1ADC755A

Q36439933-25708A21-4115-43A9-ABFC-847EE0DB6CF5

Q36439933-2718EC20-3B2E-4DCF-99B8-8A752C2A76B6

P304

Q36439933-0F5A87AE-AD97-4832-9AE8-301D536FCE75

P31

Q36439933-6B0F9FB5-8408-4401-A04E-3CA64500CF1C

P356

Q36439933-DED307EF-5EA6-4756-9E3D-44472FA1809C

P433

Q36439933-0F1FEEA2-78C6-40A2-84C4-916B61874E22

P478

Q36439933-017AFB32-B30F-4664-BFF0-AA2424883481

P577

Q36439933-86016253-3BE3-4487-933C-0B987233012A

P698

Q36439933-7A4673E4-FC8E-419C-B0A2-11A1A862B6BF

P921

Q36439933-E2C37AEC-9CA6-4986-B565-2DF086088085

P932

Q36439933-E320FDD8-BA7F-4577-8BED-CA362625D702

P356

J.CYTO.2012.03.027

P1433

P1476

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

@en

P2093

Joanna M Brell

http://www.w3.org/2001/XMLSchema#string

Susan G Dorsey

http://www.w3.org/2001/XMLSchema#string

Tanya J Lehky

http://www.w3.org/2001/XMLSchema#string

Xiao-Min Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model

Hyperalgesia and allodynia: peripheral mechanisms

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways

Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation

Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin.

Patterns and severity of conduction abnormalities in Guillain-Barré syndrome.

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.

A cascade of cytokines mediates mechanical inflammatory hypernociception in mice.

P304

3-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CYTO.2012.03.027

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22537849

http://www.w3.org/2001/XMLSchema#string

P921

P932

3512191

http://www.w3.org/2001/XMLSchema#string